ETHSX Mutual Fund

NAV$13.28

Fund Essentials - as of Feb 28, 2026

Net Assets
$540M
Expense Ratio
1.18%
Dividend Yield (Current)
7.41%
Holdings
44
Inception Date
Jul 26, 1985
Fund Family
Eaton Vance
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-0.75%
1 Year+10.74%
3 Year+5.20%
5 Year+3.88%
10 Year+8.25%

Asset Allocation

Stocks: 99.97%
Other: 0.03%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.33%
ABBVAbbvie Inc6.66%
AZN:LNAstraZeneca PLC6.54%
JNJJohnson & Johnson6.28%
ROG:SMRoche Holding Ag5.85%
Top 10 Concentration: 55.71%Report Date: Feb 28, 2026
Download all 44 holdings for ETHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.41%
Frequency
Annually
Latest Distribution
$1.21
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

ETHSX Mutual Fund Overview

ETHSX Mutual Fund (Eaton Vance Worldwide Health Sciences Fund Class A) is managed by Eaton Vance with $539.8M in net assets. ETHSX expense ratio is 1.18%, holding 44 positions across sectors including Health Care, Unknown, Financials. Inception date: 1985-07-26.

ETHSX performance shows a YTD return of -0.75%. The 1-year return is 10.74% and the 5-year return is 3.88%. ETHSX dividend yield stands at 7.41%, paid annually.

ETHSX top holdings include Eli Lilly & Co (11.3%), Abbvie Inc (6.7%), AstraZeneca PLC (6.5%), Johnson & Johnson (6.3%), Roche Holding Ag (5.8%). View all ETHSX holdings, sector breakdown, or dividend history.

ETHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ETHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.